img

Global Nucleic Acid Multiplex Assays Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Nucleic Acid Multiplex Assays Market Insights, Forecast to 2034

Multiplex Nucleic Acid Assay for Identification of Microorganisms and Resistance Markers from Positive Blood Cultures - Class II Special Controls Guideline for Industry and Food and Drug Administration Staff
Market Analysis and InsightsGlobal Nucleic Acid Multiplex Assays Market
Global Nucleic Acid Multiplex Assays market is expected to reach to US$ million in 2023, with a positive growth of %, compared with US$ million in 2022. Backed with the increasing demand from downstream industries, Nucleic Acid Multiplex Assays industry is evaluated to reach US$ million in 2033. The CAGR will be % during 2023 to 2033.
Globally, Nucleic Acid Multiplex Assays key companies include Abcam, Becton, Dickinson and Company, Merck KGaA, Agilent Technologies, Bio-Techne, Shimadzu Biotech, Thermo Fisher Scientific and Bio-Rad Laboratories, etc. Abcam, Becton, Dickinson and Company are top 3 players and held % share in total in 2022.
When considering the consumption regions, % revenue of Nucleic Acid Multiplex Assays were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033 and the share will be % in 2033. Moreover, China, plays a key role in the whole Nucleic Acid Multiplex Assays market and estimated to attract more attentions from industry insiders and investors.
Nucleic Acid Multiplex Assays can be divided into Planar Nucleic Acid Assays, Bead-Based Nucleic Acid Assays and Other Nucleic Acid Assays,, etc. Planar Nucleic Acid Assays is the mainstream product in the market, accounting for % revenue share globally in 2022 and the proportion will be % in 2033.
Nucleic Acid Multiplex Assays is widely used in various fields, such as Pharmaceutical & Biotechnology Companies, Hospitals & Research Institutes, Reference Laboratories and Other End Users, etc. Pharmaceutical & Biotechnology Companies provides greatest supports to the Nucleic Acid Multiplex Assays industry development. In 2022, global % revenue of Nucleic Acid Multiplex Assays went into Pharmaceutical & Biotechnology Companies filed and the proportion will reach to % in 2033.
Report Covers
This report presents an overview of global Nucleic Acid Multiplex Assays market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global Nucleic Acid Multiplex Assays market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


Abcam
Becton
Dickinson and Company
Merck KGaA
Agilent Technologies
Bio-Techne
Shimadzu Biotech
Thermo Fisher Scientific
Bio-Rad Laboratories
Qiagen
Luminex Corporation
Segment by Type
Planar Nucleic Acid Assays
Bead-Based Nucleic Acid Assays
Other Nucleic Acid Assays

Segment by Application


Pharmaceutical & Biotechnology Companies
Hospitals & Research Institutes
Reference Laboratories
Other End Users
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, Nucleic Acid Multiplex Assays introduction, etc. Nucleic Acid Multiplex Assays Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of Nucleic Acid Multiplex Assays
Chapter 13Methodology and Data Sources adopted by MRAResearch

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Nucleic Acid Multiplex Assays Market Size Growth Rate by Type, 2018 VS 2022 VS 2033
1.2.2 Planar Nucleic Acid Assays
1.2.3 Bead-Based Nucleic Acid Assays
1.2.4 Other Nucleic Acid Assays
1.3 Market by Application
1.3.1 Global Nucleic Acid Multiplex Assays Market Size Growth Rate by Application, 2018 VS 2022 VS 2033
1.3.2 Pharmaceutical & Biotechnology Companies
1.3.3 Hospitals & Research Institutes
1.3.4 Reference Laboratories
1.3.5 Other End Users
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Nucleic Acid Multiplex Assays Market Perspective (2018-2033)
2.2 Global Nucleic Acid Multiplex Assays Growth Trends by Region
2.2.1 Nucleic Acid Multiplex Assays Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Nucleic Acid Multiplex Assays Historic Market Size by Region (2018-2023)
2.2.3 Nucleic Acid Multiplex Assays Forecasted Market Size by Region (2024-2033)
2.3 Nucleic Acid Multiplex Assays Market Dynamics
2.3.1 Nucleic Acid Multiplex Assays Industry Trends
2.3.2 Nucleic Acid Multiplex Assays Market Drivers
2.3.3 Nucleic Acid Multiplex Assays Market Challenges
2.3.4 Nucleic Acid Multiplex Assays Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Nucleic Acid Multiplex Assays by Players
3.1.1 Global Nucleic Acid Multiplex Assays Revenue by Players (2018-2023)
3.1.2 Global Nucleic Acid Multiplex Assays Revenue Market Share by Players (2018-2023)
3.2 Global Nucleic Acid Multiplex Assays Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Nucleic Acid Multiplex Assays, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Nucleic Acid Multiplex Assays Market Concentration Ratio
3.4.1 Global Nucleic Acid Multiplex Assays Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Nucleic Acid Multiplex Assays Revenue in 2022
3.5 Global Key Players of Nucleic Acid Multiplex Assays Head office and Area Served
3.6 Global Key Players of Nucleic Acid Multiplex Assays, Product and Application
3.7 Global Key Players of Nucleic Acid Multiplex Assays, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Nucleic Acid Multiplex Assays Breakdown Data by Type
4.1 Global Nucleic Acid Multiplex Assays Historic Market Size by Type (2018-2023)
4.2 Global Nucleic Acid Multiplex Assays Forecasted Market Size by Type (2024-2033)
5 Nucleic Acid Multiplex Assays Breakdown Data by Application
5.1 Global Nucleic Acid Multiplex Assays Historic Market Size by Application (2018-2023)
5.2 Global Nucleic Acid Multiplex Assays Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Nucleic Acid Multiplex Assays Market Size (2018-2033)
6.2 North America Nucleic Acid Multiplex Assays Market Size by Type
6.2.1 North America Nucleic Acid Multiplex Assays Market Size by Type (2018-2023)
6.2.2 North America Nucleic Acid Multiplex Assays Market Size by Type (2024-2033)
6.2.3 North America Nucleic Acid Multiplex Assays Market Share by Type (2018-2033)
6.3 North America Nucleic Acid Multiplex Assays Market Size by Application
6.3.1 North America Nucleic Acid Multiplex Assays Market Size by Application (2018-2023)
6.3.2 North America Nucleic Acid Multiplex Assays Market Size by Application (2024-2033)
6.3.3 North America Nucleic Acid Multiplex Assays Market Share by Application (2018-2033)
6.4 North America Nucleic Acid Multiplex Assays Market Size by Country
6.4.1 North America Nucleic Acid Multiplex Assays Market Size by Country: 2018 VS 2022 VS 2033
6.4.2 North America Nucleic Acid Multiplex Assays Market Size by Country (2018-2023)
6.4.3 North America Nucleic Acid Multiplex Assays Market Size by Country (2024-2033)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Nucleic Acid Multiplex Assays Market Size (2018-2033)
7.2 Europe Nucleic Acid Multiplex Assays Market Size by Type
7.2.1 Europe Nucleic Acid Multiplex Assays Market Size by Type (2018-2023)
7.2.2 Europe Nucleic Acid Multiplex Assays Market Size by Type (2024-2033)
7.2.3 Europe Nucleic Acid Multiplex Assays Market Share by Type (2018-2033)
7.3 Europe Nucleic Acid Multiplex Assays Market Size by Application
7.3.1 Europe Nucleic Acid Multiplex Assays Market Size by Application (2018-2023)
7.3.2 Europe Nucleic Acid Multiplex Assays Market Size by Application (2024-2033)
7.3.3 Europe Nucleic Acid Multiplex Assays Market Share by Application (2018-2033)
7.4 Europe Nucleic Acid Multiplex Assays Market Size by Country
7.4.1 Europe Nucleic Acid Multiplex Assays Market Size by Country: 2018 VS 2022 VS 2033
7.4.2 Europe Nucleic Acid Multiplex Assays Market Size by Country (2018-2023)
7.4.3 Europe Nucleic Acid Multiplex Assays Market Size by Country (2024-2033)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Nucleic Acid Multiplex Assays Market Size (2018-2033)
8.2 China Nucleic Acid Multiplex Assays Market Size by Type
8.2.1 China Nucleic Acid Multiplex Assays Market Size by Type (2018-2023)
8.2.2 China Nucleic Acid Multiplex Assays Market Size by Type (2024-2033)
8.2.3 China Nucleic Acid Multiplex Assays Market Share by Type (2018-2033)
8.3 China Nucleic Acid Multiplex Assays Market Size by Application
8.3.1 China Nucleic Acid Multiplex Assays Market Size by Application (2018-2023)
8.3.2 China Nucleic Acid Multiplex Assays Market Size by Application (2024-2033)
8.3.3 China Nucleic Acid Multiplex Assays Market Share by Application (2018-2033)
9 Asia (excluding China)
9.1 Asia Nucleic Acid Multiplex Assays Market Size (2018-2033)
9.2 Asia Nucleic Acid Multiplex Assays Market Size by Type
9.2.1 Asia Nucleic Acid Multiplex Assays Market Size by Type (2018-2023)
9.2.2 Asia Nucleic Acid Multiplex Assays Market Size by Type (2024-2033)
9.2.3 Asia Nucleic Acid Multiplex Assays Market Share by Type (2018-2033)
9.3 Asia Nucleic Acid Multiplex Assays Market Size by Application
9.3.1 Asia Nucleic Acid Multiplex Assays Market Size by Application (2018-2023)
9.3.2 Asia Nucleic Acid Multiplex Assays Market Size by Application (2024-2033)
9.3.3 Asia Nucleic Acid Multiplex Assays Market Share by Application (2018-2033)
9.4 Asia Nucleic Acid Multiplex Assays Market Size by Region
9.4.1 Asia Nucleic Acid Multiplex Assays Market Size by Region: 2018 VS 2022 VS 2033
9.4.2 Asia Nucleic Acid Multiplex Assays Market Size by Region (2018-2023)
9.4.3 Asia Nucleic Acid Multiplex Assays Market Size by Region (2024-2033)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Nucleic Acid Multiplex Assays Market Size (2018-2033)
10.2 Middle East, Africa, and Latin America Nucleic Acid Multiplex Assays Market Size by Type
10.2.1 Middle East, Africa, and Latin America Nucleic Acid Multiplex Assays Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Nucleic Acid Multiplex Assays Market Size by Type (2024-2033)
10.2.3 Middle East, Africa, and Latin America Nucleic Acid Multiplex Assays Market Share by Type (2018-2033)
10.3 Middle East, Africa, and Latin America Nucleic Acid Multiplex Assays Market Size by Application
10.3.1 Middle East, Africa, and Latin America Nucleic Acid Multiplex Assays Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Nucleic Acid Multiplex Assays Market Size by Application (2024-2033)
10.3.3 Middle East, Africa, and Latin America Nucleic Acid Multiplex Assays Market Share by Application (2018-2033)
10.4 Middle East, Africa, and Latin America Nucleic Acid Multiplex Assays Market Size by Country
10.4.1 Middle East, Africa, and Latin America Nucleic Acid Multiplex Assays Market Size by Country: 2018 VS 2022 VS 2033
10.4.2 Middle East, Africa, and Latin America Nucleic Acid Multiplex Assays Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Nucleic Acid Multiplex Assays Market Size by Country (2024-2033)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Abcam
11.1.1 Abcam Company Details
11.1.2 Abcam Business Overview
11.1.3 Abcam Nucleic Acid Multiplex Assays Introduction
11.1.4 Abcam Revenue in Nucleic Acid Multiplex Assays Business (2018-2023)
11.1.5 Abcam Recent Developments
11.2 Becton
11.2.1 Becton Company Details
11.2.2 Becton Business Overview
11.2.3 Becton Nucleic Acid Multiplex Assays Introduction
11.2.4 Becton Revenue in Nucleic Acid Multiplex Assays Business (2018-2023)
11.2.5 Becton Recent Developments
11.3 Dickinson and Company
11.3.1 Dickinson and Company Company Details
11.3.2 Dickinson and Company Business Overview
11.3.3 Dickinson and Company Nucleic Acid Multiplex Assays Introduction
11.3.4 Dickinson and Company Revenue in Nucleic Acid Multiplex Assays Business (2018-2023)
11.3.5 Dickinson and Company Recent Developments
11.4 Merck KGaA
11.4.1 Merck KGaA Company Details
11.4.2 Merck KGaA Business Overview
11.4.3 Merck KGaA Nucleic Acid Multiplex Assays Introduction
11.4.4 Merck KGaA Revenue in Nucleic Acid Multiplex Assays Business (2018-2023)
11.4.5 Merck KGaA Recent Developments
11.5 Agilent Technologies
11.5.1 Agilent Technologies Company Details
11.5.2 Agilent Technologies Business Overview
11.5.3 Agilent Technologies Nucleic Acid Multiplex Assays Introduction
11.5.4 Agilent Technologies Revenue in Nucleic Acid Multiplex Assays Business (2018-2023)
11.5.5 Agilent Technologies Recent Developments
11.6 Bio-Techne
11.6.1 Bio-Techne Company Details
11.6.2 Bio-Techne Business Overview
11.6.3 Bio-Techne Nucleic Acid Multiplex Assays Introduction
11.6.4 Bio-Techne Revenue in Nucleic Acid Multiplex Assays Business (2018-2023)
11.6.5 Bio-Techne Recent Developments
11.7 Shimadzu Biotech
11.7.1 Shimadzu Biotech Company Details
11.7.2 Shimadzu Biotech Business Overview
11.7.3 Shimadzu Biotech Nucleic Acid Multiplex Assays Introduction
11.7.4 Shimadzu Biotech Revenue in Nucleic Acid Multiplex Assays Business (2018-2023)
11.7.5 Shimadzu Biotech Recent Developments
11.8 Thermo Fisher Scientific
11.8.1 Thermo Fisher Scientific Company Details
11.8.2 Thermo Fisher Scientific Business Overview
11.8.3 Thermo Fisher Scientific Nucleic Acid Multiplex Assays Introduction
11.8.4 Thermo Fisher Scientific Revenue in Nucleic Acid Multiplex Assays Business (2018-2023)
11.8.5 Thermo Fisher Scientific Recent Developments
11.9 Bio-Rad Laboratories
11.9.1 Bio-Rad Laboratories Company Details
11.9.2 Bio-Rad Laboratories Business Overview
11.9.3 Bio-Rad Laboratories Nucleic Acid Multiplex Assays Introduction
11.9.4 Bio-Rad Laboratories Revenue in Nucleic Acid Multiplex Assays Business (2018-2023)
11.9.5 Bio-Rad Laboratories Recent Developments
11.10 Qiagen
11.10.1 Qiagen Company Details
11.10.2 Qiagen Business Overview
11.10.3 Qiagen Nucleic Acid Multiplex Assays Introduction
11.10.4 Qiagen Revenue in Nucleic Acid Multiplex Assays Business (2018-2023)
11.10.5 Qiagen Recent Developments
11.11 Luminex Corporation
11.11.1 Luminex Corporation Company Details
11.11.2 Luminex Corporation Business Overview
11.11.3 Luminex Corporation Nucleic Acid Multiplex Assays Introduction
11.11.4 Luminex Corporation Revenue in Nucleic Acid Multiplex Assays Business (2018-2023)
11.11.5 Luminex Corporation Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Nucleic Acid Multiplex Assays Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2033
Table 2. Key Players of Planar Nucleic Acid Assays
Table 3. Key Players of Bead-Based Nucleic Acid Assays
Table 4. Key Players of Other Nucleic Acid Assays
Table 5. Global Nucleic Acid Multiplex Assays Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2033
Table 6. Global Nucleic Acid Multiplex Assays Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 7. Global Nucleic Acid Multiplex Assays Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Nucleic Acid Multiplex Assays Market Share by Region (2018-2023)
Table 9. Global Nucleic Acid Multiplex Assays Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 10. Global Nucleic Acid Multiplex Assays Market Share by Region (2024-2033)
Table 11. Nucleic Acid Multiplex Assays Market Trends
Table 12. Nucleic Acid Multiplex Assays Market Drivers
Table 13. Nucleic Acid Multiplex Assays Market Challenges
Table 14. Nucleic Acid Multiplex Assays Market Restraints
Table 15. Global Nucleic Acid Multiplex Assays Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Nucleic Acid Multiplex Assays Revenue Share by Players (2018-2023)
Table 17. Global Top Nucleic Acid Multiplex Assays by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nucleic Acid Multiplex Assays as of 2022)
Table 18. Global Nucleic Acid Multiplex Assays Industry Ranking 2021 VS 2022 VS 2023
Table 19. Global 5 Largest Players Market Share by Nucleic Acid Multiplex Assays Revenue (CR5 and HHI) & (2018-2023)
Table 20. Global Key Players of Nucleic Acid Multiplex Assays, Headquarters and Area Served
Table 21. Global Key Players of Nucleic Acid Multiplex Assays, Product and Application
Table 22. Global Key Players of Nucleic Acid Multiplex Assays, Product and Application
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Nucleic Acid Multiplex Assays Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Nucleic Acid Multiplex Assays Revenue Market Share by Type (2018-2023)
Table 26. Global Nucleic Acid Multiplex Assays Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 27. Global Nucleic Acid Multiplex Assays Revenue Market Share by Type (2024-2033)
Table 28. Global Nucleic Acid Multiplex Assays Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Nucleic Acid Multiplex Assays Revenue Share by Application (2018-2023)
Table 30. Global Nucleic Acid Multiplex Assays Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 31. Global Nucleic Acid Multiplex Assays Revenue Share by Application (2024-2033)
Table 32. North America Nucleic Acid Multiplex Assays Market Size by Type (2018-2023) & (US$ Million)
Table 33. North America Nucleic Acid Multiplex Assays Market Size by Type (2024-2033) & (US$ Million)
Table 34. North America Nucleic Acid Multiplex Assays Market Size by Application (2018-2023) & (US$ Million)
Table 35. North America Nucleic Acid Multiplex Assays Market Size by Application (2024-2033) & (US$ Million)
Table 36. North America Nucleic Acid Multiplex Assays Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 37. North America Nucleic Acid Multiplex Assays Market Size by Country (2018-2023) & (US$ Million)
Table 38. North America Nucleic Acid Multiplex Assays Market Size by Country (2024-2033) & (US$ Million)
Table 39. Europe Nucleic Acid Multiplex Assays Market Size by Type (2018-2023) & (US$ Million)
Table 40. Europe Nucleic Acid Multiplex Assays Market Size by Type (2024-2033) & (US$ Million)
Table 41. Europe Nucleic Acid Multiplex Assays Market Size by Application (2018-2023) & (US$ Million)
Table 42. Europe Nucleic Acid Multiplex Assays Market Size by Application (2024-2033) & (US$ Million)
Table 43. Europe Nucleic Acid Multiplex Assays Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Europe Nucleic Acid Multiplex Assays Market Size by Country (2018-2023) & (US$ Million)
Table 45. Europe Nucleic Acid Multiplex Assays Market Size by Country (2024-2033) & (US$ Million)
Table 46. China Nucleic Acid Multiplex Assays Market Size by Type (2018-2023) & (US$ Million)
Table 47. China Nucleic Acid Multiplex Assays Market Size by Type (2024-2033) & (US$ Million)
Table 48. China Nucleic Acid Multiplex Assays Market Size by Application (2018-2023) & (US$ Million)
Table 49. China Nucleic Acid Multiplex Assays Market Size by Application (2024-2033) & (US$ Million)
Table 50. Asia Nucleic Acid Multiplex Assays Market Size by Type (2018-2023) & (US$ Million)
Table 51. Asia Nucleic Acid Multiplex Assays Market Size by Type (2024-2033) & (US$ Million)
Table 52. Asia Nucleic Acid Multiplex Assays Market Size by Application (2018-2023) & (US$ Million)
Table 53. Asia Nucleic Acid Multiplex Assays Market Size by Application (2024-2033) & (US$ Million)
Table 54. Asia Nucleic Acid Multiplex Assays Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 55. Asia Nucleic Acid Multiplex Assays Market Size by Region (2018-2023) & (US$ Million)
Table 56. Asia Nucleic Acid Multiplex Assays Market Size by Region (2024-2033) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Nucleic Acid Multiplex Assays Market Size by Type (2018-2023) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Nucleic Acid Multiplex Assays Market Size by Type (2024-2033) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Nucleic Acid Multiplex Assays Market Size by Application (2018-2023) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Nucleic Acid Multiplex Assays Market Size by Application (2024-2033) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Nucleic Acid Multiplex Assays Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 62. Middle East, Africa, and Latin America Nucleic Acid Multiplex Assays Market Size by Country (2018-2023) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Nucleic Acid Multiplex Assays Market Size by Country (2024-2033) & (US$ Million)
Table 64. Abcam Company Details
Table 65. Abcam Business Overview
Table 66. Abcam Nucleic Acid Multiplex Assays Product
Table 67. Abcam Revenue in Nucleic Acid Multiplex Assays Business (2018-2023) & (US$ Million)
Table 68. Abcam Recent Developments
Table 69. Becton Company Details
Table 70. Becton Business Overview
Table 71. Becton Nucleic Acid Multiplex Assays Product
Table 72. Becton Revenue in Nucleic Acid Multiplex Assays Business (2018-2023) & (US$ Million)
Table 73. Becton Recent Developments
Table 74. Dickinson and Company Company Details
Table 75. Dickinson and Company Business Overview
Table 76. Dickinson and Company Nucleic Acid Multiplex Assays Product
Table 77. Dickinson and Company Revenue in Nucleic Acid Multiplex Assays Business (2018-2023) & (US$ Million)
Table 78. Dickinson and Company Recent Developments
Table 79. Merck KGaA Company Details
Table 80. Merck KGaA Business Overview
Table 81. Merck KGaA Nucleic Acid Multiplex Assays Product
Table 82. Merck KGaA Revenue in Nucleic Acid Multiplex Assays Business (2018-2023) & (US$ Million)
Table 83. Merck KGaA Recent Developments
Table 84. Agilent Technologies Company Details
Table 85. Agilent Technologies Business Overview
Table 86. Agilent Technologies Nucleic Acid Multiplex Assays Product
Table 87. Agilent Technologies Revenue in Nucleic Acid Multiplex Assays Business (2018-2023) & (US$ Million)
Table 88. Agilent Technologies Recent Developments
Table 89. Bio-Techne Company Details
Table 90. Bio-Techne Business Overview
Table 91. Bio-Techne Nucleic Acid Multiplex Assays Product
Table 92. Bio-Techne Revenue in Nucleic Acid Multiplex Assays Business (2018-2023) & (US$ Million)
Table 93. Bio-Techne Recent Developments
Table 94. Shimadzu Biotech Company Details
Table 95. Shimadzu Biotech Business Overview
Table 96. Shimadzu Biotech Nucleic Acid Multiplex Assays Product
Table 97. Shimadzu Biotech Revenue in Nucleic Acid Multiplex Assays Business (2018-2023) & (US$ Million)
Table 98. Shimadzu Biotech Recent Developments
Table 99. Thermo Fisher Scientific Company Details
Table 100. Thermo Fisher Scientific Business Overview
Table 101. Thermo Fisher Scientific Nucleic Acid Multiplex Assays Product
Table 102. Thermo Fisher Scientific Revenue in Nucleic Acid Multiplex Assays Business (2018-2023) & (US$ Million)
Table 103. Thermo Fisher Scientific Recent Developments
Table 104. Bio-Rad Laboratories Company Details
Table 105. Bio-Rad Laboratories Business Overview
Table 106. Bio-Rad Laboratories Nucleic Acid Multiplex Assays Product
Table 107. Bio-Rad Laboratories Revenue in Nucleic Acid Multiplex Assays Business (2018-2023) & (US$ Million)
Table 108. Bio-Rad Laboratories Recent Developments
Table 109. Qiagen Company Details
Table 110. Qiagen Business Overview
Table 111. Qiagen Nucleic Acid Multiplex Assays Product
Table 112. Qiagen Revenue in Nucleic Acid Multiplex Assays Business (2018-2023) & (US$ Million)
Table 113. Qiagen Recent Developments
Table 114. Luminex Corporation Company Details
Table 115. Luminex Corporation Business Overview
Table 116. Luminex Corporation Nucleic Acid Multiplex Assays Product
Table 117. Luminex Corporation Revenue in Nucleic Acid Multiplex Assays Business (2018-2023) & (US$ Million)
Table 118. Luminex Corporation Recent Developments
Table 119. Research Programs/Design for This Report
Table 120. Key Data Information from Secondary Sources
Table 121. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Nucleic Acid Multiplex Assays Market Size Growth Rate by Type, 2018 VS 2022 VS 2033 (US$ Million)
Figure 2. Global Nucleic Acid Multiplex Assays Market Share by Type: 2022 VS 2033
Figure 3. Planar Nucleic Acid Assays Features
Figure 4. Bead-Based Nucleic Acid Assays Features
Figure 5. Other Nucleic Acid Assays Features
Figure 6. Global Nucleic Acid Multiplex Assays Market Size Growth Rate by Application, 2018 VS 2022 VS 2033 (US$ Million)
Figure 7. Global Nucleic Acid Multiplex Assays Market Share by Application: 2022 VS 2033
Figure 8. Pharmaceutical & Biotechnology Companies Case Studies
Figure 9. Hospitals & Research Institutes Case Studies
Figure 10. Reference Laboratories Case Studies
Figure 11. Other End Users Case Studies
Figure 12. Nucleic Acid Multiplex Assays Report Years Considered
Figure 13. Global Nucleic Acid Multiplex Assays Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 14. Global Nucleic Acid Multiplex Assays Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 15. Global Nucleic Acid Multiplex Assays Market Share by Region: 2022 VS 2033
Figure 16. Global Nucleic Acid Multiplex Assays Market Share by Players in 2022
Figure 17. Global Top Nucleic Acid Multiplex Assays Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nucleic Acid Multiplex Assays as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Nucleic Acid Multiplex Assays Revenue in 2022
Figure 19. North America Nucleic Acid Multiplex Assays Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 20. North America Nucleic Acid Multiplex Assays Market Share by Type (2018-2033)
Figure 21. North America Nucleic Acid Multiplex Assays Market Share by Application (2018-2033)
Figure 22. North America Nucleic Acid Multiplex Assays Market Share by Country (2018-2033)
Figure 23. United States Nucleic Acid Multiplex Assays Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Canada Nucleic Acid Multiplex Assays Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. Europe Nucleic Acid Multiplex Assays Market Size YoY (2018-2033) & (US$ Million)
Figure 26. Europe Nucleic Acid Multiplex Assays Market Share by Type (2018-2033)
Figure 27. Europe Nucleic Acid Multiplex Assays Market Share by Application (2018-2033)
Figure 28. Europe Nucleic Acid Multiplex Assays Market Share by Country (2018-2033)
Figure 29. Germany Nucleic Acid Multiplex Assays Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. France Nucleic Acid Multiplex Assays Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. U.K. Nucleic Acid Multiplex Assays Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Italy Nucleic Acid Multiplex Assays Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Russia Nucleic Acid Multiplex Assays Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Nordic Countries Nucleic Acid Multiplex Assays Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. China Nucleic Acid Multiplex Assays Market Size YoY (2018-2033) & (US$ Million)
Figure 36. China Nucleic Acid Multiplex Assays Market Share by Type (2018-2033)
Figure 37. China Nucleic Acid Multiplex Assays Market Share by Application (2018-2033)
Figure 38. Asia Nucleic Acid Multiplex Assays Market Size YoY (2018-2033) & (US$ Million)
Figure 39. Asia Nucleic Acid Multiplex Assays Market Share by Type (2018-2033)
Figure 40. Asia Nucleic Acid Multiplex Assays Market Share by Application (2018-2033)
Figure 41. Asia Nucleic Acid Multiplex Assays Market Share by Region (2018-2033)
Figure 42. Japan Nucleic Acid Multiplex Assays Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. South Korea Nucleic Acid Multiplex Assays Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. China Taiwan Nucleic Acid Multiplex Assays Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Southeast Asia Nucleic Acid Multiplex Assays Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. India Nucleic Acid Multiplex Assays Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Australia Nucleic Acid Multiplex Assays Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 48. Middle East, Africa, and Latin America Nucleic Acid Multiplex Assays Market Size YoY (2018-2033) & (US$ Million)
Figure 49. Middle East, Africa, and Latin America Nucleic Acid Multiplex Assays Market Share by Type (2018-2033)
Figure 50. Middle East, Africa, and Latin America Nucleic Acid Multiplex Assays Market Share by Application (2018-2033)
Figure 51. Middle East, Africa, and Latin America Nucleic Acid Multiplex Assays Market Share by Country (2018-2033)
Figure 52. Brazil Nucleic Acid Multiplex Assays Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 53. Mexico Nucleic Acid Multiplex Assays Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 54. Turkey Nucleic Acid Multiplex Assays Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 55. Saudi Arabia Nucleic Acid Multiplex Assays Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 56. Israel Nucleic Acid Multiplex Assays Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 57. GCC Countries Nucleic Acid Multiplex Assays Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 58. Abcam Revenue Growth Rate in Nucleic Acid Multiplex Assays Business (2018-2023)
Figure 59. Becton Revenue Growth Rate in Nucleic Acid Multiplex Assays Business (2018-2023)
Figure 60. Dickinson and Company Revenue Growth Rate in Nucleic Acid Multiplex Assays Business (2018-2023)
Figure 61. Merck KGaA Revenue Growth Rate in Nucleic Acid Multiplex Assays Business (2018-2023)
Figure 62. Agilent Technologies Revenue Growth Rate in Nucleic Acid Multiplex Assays Business (2018-2023)
Figure 63. Bio-Techne Revenue Growth Rate in Nucleic Acid Multiplex Assays Business (2018-2023)
Figure 64. Shimadzu Biotech Revenue Growth Rate in Nucleic Acid Multiplex Assays Business (2018-2023)
Figure 65. Thermo Fisher Scientific Revenue Growth Rate in Nucleic Acid Multiplex Assays Business (2018-2023)
Figure 66. Bio-Rad Laboratories Revenue Growth Rate in Nucleic Acid Multiplex Assays Business (2018-2023)
Figure 67. Qiagen Revenue Growth Rate in Nucleic Acid Multiplex Assays Business (2018-2023)
Figure 68. Luminex Corporation Revenue Growth Rate in Nucleic Acid Multiplex Assays Business (2018-2023)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries